Univest
Univest
  • Markets
  • Alembic Pharma Share Price: 12.3% CAGR in 3 Years as the Vadodara-Based Drug Maker Compares With Zydus Lifesciences, Lupin and Glenmark Pharmaceuticals

    • November 19, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    Alembic Pharma Share Price: 12.3% CAGR in 3 Years as the Vadodara-Based Drug Maker Compares With Zydus Lifesciences, Lupin and Glenmark Pharmaceuticals

    Alembic Pharma share price compounded at 12.3% a year over 3 years. See how it compares with peers on returns and valuation.

    read more